Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial
暂无分享,去创建一个
A. Es‐haghi | M. Hajimoradi | M. Ghader | S. Kalantari | A. Mohazzab | Fahimeh Bagheri Amiri | M. S. Dodaran | A. Ranjbar | S. Safari | A. Ansarifar | F. Sadeghi | S. R. Banihashemi | Mojtaba Nofeli | A. R. Mokarram | Neda Ghahremanzadeh | M. Bagheri | Mohammad Hosein Fallah Mehrabadi | A. Khorasani | Ladan Mokhberalsafa | Seyed Amin Setarehdan | Safdar Masoomi | Vahideh Mohseni | Seyed Hossein Razzaz | Maryam Taghdiri | Mohsen Lofti | Masumeh Shahsavn | S. Banihashemi | M. F. Mehrabadi | Mojtaba Nofeli | Arash Mohazzab